Follow


Submissions from 2019

Defining the indications for pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients within a statewide quality improvement collaborative, Firas Abdollah, G Betrus, M Cher, Deepansh Dalela, Jacob Keeley, T Kim, B Lane, S Mansour, J Montie, E Schervish, Akshay Sood, K Swama, and James O Peabody

Evaluating the impact of lead-time bias on the observed efficacy of early salvage radiation therapy in prostate cancer: A post-hoc analysis of the RTOG 9601 trial, Firas Abdollah, Deepansh Dalela, Akshay Sood, Sohrab Arora, Hoang J. Tang, Jacob Keeley, Shaheen Alanee, Craig G. Rogers, James O Peabody, and Mani Menon

Menon-precision prostatectomy (MPP): An idea, development, exploration, assessment, long-term follow-up (IDEAL)stage 1 study, Firas Abdollah, Wooju Jeong, Deepansh Dalela, Isaac Palma-Zamora, Akshay Sood, and Mani Menon

Impact of timing on radiation therapy adverse events following radical prostatectomy, an analysis of the RTOG 9601 cohort, Lee Baumgarten, Alex Borchert, Deepansh Dalela, Akshay Sood, Sohrab Arora, Jacob Keeley, Q Trinh, Craig G. Rogers, James O Peabody, Mani Menon, and Firas Abdollah

Urine cell flow cytometry analysis of PD-L1 expression and DNA content for bladder cancer, P I. Chen, A Wang, Mustafa Deebajah, Shaheen Alanee, and B K. Patterson

The contribution of demographic, access and treatment-related factors on racial disparities in bladder cancer, A P. Cole, M J. Krimphove, S A. Fletcher, S Lipsitz, P Gild, M Preston, Mani Menon, A Kibel, and Q Trinh

A smartphone-based mobile health app to address the adverse effects of androgen deprivation therapy in men with prostate cancer, A P. Cole, D T. Pucheril, M Sun, S A. Fletcher, D L. Berry, P L. Nguyen, C Sweeney, Mani Menon, A Kibel, and Q Trinh

The changing face of surgically treated low-risk prostate cancer (PCa): A national cancer database (NCDB) analysis, A Fotouhi, Alex Borchert, Deepansh Dalela, Akshay Sood, Jacob Keeley, Sohrab Arora, Q Trinh, James O Peabody, Mani Menon, and Firas Abdollah

Keynote-676: Phase 3 study of bacillus calmette-guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction, A M. Kamat, N D. Shore, N M. Hahn, Shaheen Alanee, H Nishiyama, S Shariat, K Nam, E Kapadia, T L. Frenkl, and G D. Steinberg

VS06. Robotic-Assisted Removal of Inferior Vena Cava Filter, Judith C Lin, Amit Patel, and Craig G. Rogers

Patterns of renal mass biopsy across the MUSIC-KIDNEY statewide QI collaborative, Amit Patel, Sara Perkins, M Bazzi, R Arcot, A Johnson, J Qi, T Kim, K Ghani, E Schervish, B Lane, and Craig G. Rogers

Persistent under-utilization of adjuvant radiotherapy in patients with adverse pathological features at radical prostatectomy: A national cancer database (NCDB) analysis, Nikola Rakic, A Fotouhi, Lee Baumgarten, Alex Borchert, Deepansh Dalela, Akshay Sood, Sohrab Arora, Mani Menon, and Firas Abdollah

Extended lymph node dissection is associated with improved overall survival in patients with very high-risk prostate cancer: A national cancer database analysis, Akshay Sood, Jacob Keeley, Sohrab Arora, Deepansh Dalela, Wooju Jeong, Craig G. Rogers, James O Peabody, Mani Menon, and Firas Abdollah

Rates and patterns of metastases in patients with node-negative prostate cancer at radical prostatectomy that experience PSA failure: Post-hoc analysis of RTOG 9601 trial data, Akshay Sood, Jacob Keeley, Sohrab Arora, Deepansh Dalela, Wooju Jeong, Craig G. Rogers, James O Peabody, Mani Menon, and Firas Abdollah

New persistent opioid use after ureteroscopy for stone treatment, C Tam, P Yan, J Raisky, V Gunaseelan, T Kim, David Leavitt, C Dauw, and J M. Hollingsworth

Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer, W S. Tan, M J. Krimphove, A Cole, S Berg, M Marchese, S Lipsitz, B Loppenberg, J Nabi, Firas Abdollah, T Choueiri, A Kibel, P Sooriakumaran, and Q Trinh

Submissions from 2018

Assessing the External Validity of the Updated Prostate Cancer (PCa) Intervention Versus Observation Trial (PIVOT), Firas Abdollah, Deepansh Dalela, S Ashkay, Shaheen Alanee, Jacob Keeley, James O Peabody, Craig G. Rogers, and Mani Menon